EastWest Bioscience Inc. reported earnings results for the second quarter and six months ended January 31, 2022. For the second quarter, the company reported revenue was CAD 0.235446 million compared to CAD 0.349735 million a year ago. Net income was CAD 2.09 million compared to net loss of CAD 0.208194 million a year ago. Basic earnings per share from continuing operations was CAD 0.02.
For the six months, revenue was CAD 0.410336 million compared to CAD 0.624218 million a year ago. Net income was CAD 1.6 million compared to net loss of CAD 0.519588 million a year ago. Basic earnings per share from continuing operations was CAD 0.02 compared to basic loss per share from continuing operations of CAD 0.01 a year ago.